BCC-Breast Cancer Conference 2019 in Vienna
11.09.2018
The 16th St. Gallen International Breast Cancer Conference 2019 in Vienna is less than seven months away.
Save the Date for the 16th St. Gallen International Breast Cancer Conference.
Primary Therapy of Early Breast Cancer Vienna, Austria 20 - 23 March 2019.
More information and registration at http://www.oncoconferences.ch/bcc
News
10.04.2019 Results from E-VITA trial conducted with HER2-positive metastatic breast cancer patients
We are pleased to inform you that the results of the E-VITA study that evaluated the efficacy and tolerability of two schedules of eribulin and lapatinib in patients with trastuzumab-pretreated HER2-positive metastatic breast cancer has been published in the Anticancer Drugs.
Mehr ...01.03.2019 Evaluation of sCAIX as predictive marker for efficacy of neoadjuvant bevacizumab
A translational research study performed with samples obtained from a cohort of patients with HER2-negative breast cancer enrolled in the neoadjuvant GeparQuinto (GBG 44) trial has been published in the International Journey of Cancer.
Mehr ...04.02.2019 ESMO Breast Cancer 2019 in Berlin
ESMO Breast Cancer is an annual congress taking place on 2-4 May 2019 in Berlin, Germany.
Mehr ...01.02.2019 Results of the GeparOcto trial
We are delighted to inform you that the results of the GeparOcto phase III study designed to compare a sequential dose-dense, dose-intensified (idd) ETC (epirubicin, paclitaxel, cyclophosphamide) with weekly PM(Cb) (paclitaxel, liposomal doxorubicin, carboplatin) for neoadjuvant treatment of patients with high-risk early breast cancer have been published in the European Journal of Cancer.
Mehr ...